Accelerate Diagnostics Investor Information Center
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections. We are focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary direct from sample ID/AST system utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity.
In addition to the ID/AST system development pipeline, Accelerate Diagnostics also owns and licenses its propriety OptiChem® surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Our investor relations section offers a wealth of information regarding Accelerate’s performance to date and our strategy for the continued growth of our business. Our SEC filings are available, in addition to our recent announcements and presentations.
If you have questions or comments please contact our Investor Relations team by clicking HERE. We will be happy to help!
Provided by eSignal.